{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:47:27Z","timestamp":1791298047096,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004074","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer Society of Ontario"},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.mcn.2015.02.016","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T07:19:26Z","timestamp":1425453566000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"PA","title":["Current and future implications of basic and translational research on amyloid-\u03b2 peptide production and removal pathways"],"prefix":"10.1016","volume":"66","author":[{"given":"C.","family":"Bohm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sevalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-1863","authenticated-orcid":false,"given":"R.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schmitt-Ulms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.","family":"St George-Hyslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2015.02.016_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0006-291X(02)02999-6","article-title":"Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase","volume":"301","author":"Asai","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcn.2015.02.016_bb0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1510","key":"10.1016\/j.mcn.2015.02.016_bb0020","first-page":"e19","article-title":"Missense variant in TREML2 protects against Alzheimer's disease","volume":"35","author":"Benitez","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2015.02.016_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-7-3","article-title":"Both common variations and rare non-synonymous substitutions and small insertion\/deletions in CLU are associated with increased Alzheimer risk","volume":"7","author":"Bettens","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2015.02.016_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2012.03.030","article-title":"The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport","volume":"47","author":"Bhalla","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2015.02.016_bb0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0b013e3182452b40","article-title":"Genetic variation at CR1 increases risk of cerebral amyloid angiopathy","volume":"78","author":"Biffi","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.02.016_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-7091-6467-9_11","article-title":"Evolution of neuronal changes in the course of Alzheimer's disease","volume":"53","author":"Braak","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.mcn.2015.02.016_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.mcn.2015.02.016_bb0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2174\/15680266113139990137","article-title":"The structural evolution of beta-secretase inhibitors: a focus on the development of small-molecule inhibitors","volume":"13","author":"Butini","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecul. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0075","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/nsmb.2971","article-title":"A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers","volume":"22","author":"Cohen","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0080","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature12825","article-title":"Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease","volume":"505","author":"Cruchaga","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0095","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/bi400377p","article-title":"Development and mechanism of \u03b3-secretase modulators for Alzheimer's disease","volume":"52","author":"Crump","year":"2013","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mcn.2015.02.016_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.biopsych.2010.09.020","article-title":"What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease?","volume":"68","author":"Cummings","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mcn.2015.02.016_bb0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2015.02.016_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-4580(95)00013-5","article-title":"Correlations of synaptic and pathological markers with cognition of the elderly","volume":"16","author":"Dickson","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2015.02.016_bb0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncb960","article-title":"Reconstitution of gamma-secretase activity","volume":"5","author":"Edbauer","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0135","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.164384","article-title":"The dynamic conformational landscape of \u03b3-secretase","author":"Elad","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0140","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.2111583","article-title":"Cleavage of amyloid beta peptide during constitutive processing of its precursor","volume":"248","author":"Esch","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.2000.tb06925.x","article-title":"Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure","volume":"920","author":"Fahrenholz","year":"2000","journal-title":"Ann. N. Acad. Sci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/302702","article-title":"High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes","volume":"66","author":"Finckh","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2014.06.021","article-title":"Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice","volume":"70","author":"Fragkouli","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2015.02.016_bb0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","article-title":"aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation","volume":"3","author":"Francis","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.mcn.2015.02.016_bb0165","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/cb700073y","article-title":"Divergent synthesis of multifunctional molecular probes to elucidate the enzyme specificity of dipeptidic gamma-secretase inhibitors","volume":"2","author":"Fuwa","year":"2007","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcn.2015.02.016_bb0180","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0185","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/mds.20539","article-title":"Tau gene mutations and their effects","volume":"20","author":"Goedert","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2015.02.016_bb0190","first-page":"1828","article-title":"\u03b3-Secretase inhibitors and modulators","author":"Golde","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2015.02.016_bb0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2015.02.016_bb0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0205","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/357500a0","article-title":"Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments","volume":"357","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0210","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","article-title":"The Swedish mutation causes early-onset Alzheimer's disease by \u03b2-secretase cleavage within the secretory pathway","volume":"1","author":"Haass","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0215","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-63380-4.00003-2","article-title":"Gamma-secretase modulators: current status and future directions","volume":"53","author":"Hall","year":"2014","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0225","first-page":"1","article-title":"Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future","author":"Hampel","year":"2014","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.mcn.2015.02.016_bb0230","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0235","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.neurobiolaging.2012.07.001","article-title":"Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism","volume":"33","author":"Hazrati","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2015.02.016_bb0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0250","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy","volume":"43","author":"Hoglinger","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.mcn.2015.02.016_bb0265","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2015.02.016_bb0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2015.02.016_bb0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/77399","article-title":"Identification of the major Abeta1\u201342-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0280","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00401-014-1362-3","article-title":"PART and SNAP","volume":"128","author":"Jack","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0285","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2015.02.016_bb0290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/WNL.0000000000000386","article-title":"Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration","volume":"82","author":"Jack","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.02.016_bb0295","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0305","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer's disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.mcn.2015.02.016_bb0310","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","article-title":"Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes","volume":"67","author":"Jun","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0315","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ncb1602","article-title":"BACE1 regulates voltage-gated sodium channels and neuronal activity","volume":"9","author":"Kim","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0320","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0325","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0330","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1073\/pnas.0407640102","article-title":"The initial substrate-binding site of \u03b3-secretase is located on presenilin near the active site","volume":"102","author":"Kornilova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0335","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1073\/pnas.98.2.507","article-title":"LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes","volume":"98","author":"Laffitte","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0340","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1074\/jbc.270.8.3565","article-title":"Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain","volume":"270","author":"Lai","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0345","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0350","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0355","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1523\/JNEUROSCI.3359-12.2012","article-title":"Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes","volume":"32","author":"Lane","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0360","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0370","first-page":"125","article-title":"Structural interactions between inhibitor and substrate docking sites give insight into mechanisms of human PS1 complexes","volume":"22","author":"Li","year":"2014","journal-title":"Struct. Lond. Engl. 1993"},{"key":"10.1016\/j.mcn.2015.02.016_bb0375","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(05)79757-9","article-title":"Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease","volume":"352","author":"Lippa","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mcn.2015.02.016_bb0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrneurol.2014.232","article-title":"Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases","volume":"11","author":"Lleo","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0385","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","article-title":"Molecular structure of \u03b2-amyloid fibrils in Alzheimer's disease brain tissue","volume":"154","author":"Lu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2015.02.016_bb0390","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nature13567","article-title":"Three-dimensional structure of human \u03b3-secretase","volume":"512","author":"Lu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0395","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0400","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1074\/jbc.M113.510131","article-title":"\u03b3-Secretase associated with lipid rafts: multiple interactive pathways in the stepwise processing of \u03b2-carboxyl-terminal fragment","volume":"289","author":"Matsumura","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0405","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of A\u03b2 aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0410","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nchembio.1508","article-title":"Pharmacological chaperones stabilize retromer to limit APP processing","volume":"10","author":"Mecozzi","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0415","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer's disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol. Zurich Switz."},{"key":"10.1016\/j.mcn.2015.02.016_bb0420","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnagi.2014.00238","article-title":"Abeta degradation or cerebral perfusion? Divergent effects of multifunctional enzymes","volume":"6","author":"Miners","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0425","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0430","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nsmb.2191","article-title":"The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-\u03b2(1\u201340) peptide","volume":"19","author":"Narayan","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0435","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/bi401606f","article-title":"Rare individual amyloid-\u03b2 oligomers act on astrocytes to initiate neuronal damage","volume":"53","author":"Narayan","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mcn.2015.02.016_bb0440","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nchembio.1663","article-title":"Combating neurodegenerative disease with chemical probes and model systems","volume":"10","author":"Narayan","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0445","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1742-2094-11-95","article-title":"Deficiency of complement receptors CR2\/CR1 in Cr2 \u2212\/\u2212mice reduces the extent of secondary brain damage after closed head injury","volume":"11","author":"Neher","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mcn.2015.02.016_bb0450","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u201cArctic\u201d APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0455","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.02.016_bb0460","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","article-title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","volume":"69","author":"Ostrowitzki","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0465","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1517\/13543776.2013.821465","article-title":"Novel gamma-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012","volume":"23","author":"Pettersson","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.mcn.2015.02.016_bb0470","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/156720510793499066","article-title":"Blood\u2013brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-\u03b2 clearance in Alzheimer's disease","volume":"7","author":"Pflanzner","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcn.2015.02.016_bb0475","doi-asserted-by":"crossref","first-page":"e87014","DOI":"10.1371\/journal.pone.0087014","article-title":"Regulation of amyloid precursor protein processing by serotonin signaling","volume":"9","author":"Pimenova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2015.02.016_bb0480","doi-asserted-by":"crossref","first-page":"924-924","DOI":"10.1126\/science.1234089","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models.\u201d","volume":"340","author":"Price","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0485","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0490","doi-asserted-by":"crossref","first-page":"e20405","DOI":"10.1371\/journal.pone.0020405","article-title":"Increased secreted amyloid precursor protein-\u03b1 (sAPP\u03b1) in severe autism: proposal of a specific, anabolic pathway and putative biomarker","volume":"6","author":"Ray","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2015.02.016_bb0495","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12415","article-title":"Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease","volume":"500","author":"Rhinn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0500","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0033-1359312","article-title":"Neuroimaging biomarkers of neurodegenerative diseases and dementia","volume":"33","author":"Risacher","year":"2013","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0505","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0510","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0515","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.02.016_bb0520","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0525","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1074\/jbc.M112.439570","article-title":"A lipoprotein receptor cluster IV mutant preferentially binds amyloid-\u03b2 and regulates its clearance from the mouse brain","volume":"288","author":"Sagare","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0530","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnagi.2014.00290","article-title":"New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy","volume":"6","author":"Saito","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0535","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0b013e3182309fa5","article-title":"A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease","volume":"77","author":"Salloway","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.02.016_bb0540","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.molmed.2014.10.002","article-title":"A network approach to clinical intervention in neurodegenerative diseases","volume":"20","author":"Santiago","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0545","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0550","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0555","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrneurol.2010.71","article-title":"Systemic inflammatory cells fight off neurodegenerative disease","volume":"6","author":"Schwartz","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0560","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1242\/jcs.103440","article-title":"The retromer complex \u2014 endosomal protein recycling and beyond","volume":"125","author":"Seaman","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0565","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0570","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jpi.12200","article-title":"Melatonin stimulates the nonamyloidogenic processing of betaAPP through the positive transcriptional regulation of ADAM10 and ADAM17","volume":"58","author":"Shukla","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.mcn.2015.02.016_bb0575","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1126\/science.1691865","article-title":"Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing","volume":"248","author":"Sisodia","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0580","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnagi.2014.00114","article-title":"Immunotherapy for Alzheimer's disease: past, present and future","volume":"6","author":"Spencer","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0585","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(08)61047-8","article-title":"Will anti-amyloid therapies work for Alzheimer's disease?","volume":"372","author":"St George-Hyslop","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.mcn.2015.02.016_bb0590","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate \u03b2-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Suh","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2015.02.016_bb0595","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"Gamma-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment","volume":"29","author":"Takami","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.mcn.2015.02.016_bb0600","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.1402171111","article-title":"Allosteric regulation of \u03b3-secretase activity by a phenylimidazole-type \u03b3-secretase modulator","volume":"111","author":"Takeo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0605","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12035-013-8475-x","article-title":"The NLRP3 inflammasome in Alzheimer's disease","volume":"48","author":"Tan","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0610","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00005072-196310000-00005","article-title":"The fine structure of neurofibrillary tangles in Alzheimer's disease","volume":"22","author":"Terry","year":"1963","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0615","doi-asserted-by":"crossref","first-page":"924-924","DOI":"10.1126\/science.1233937","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models.\u201d","volume":"340","author":"Tesseur","year":"2013","journal-title":"Science"},{"issue":"Suppl. 4","key":"10.1016\/j.mcn.2015.02.016_bb0620","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.3233\/JAD-141461","article-title":"Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies","volume":"42","author":"Thal","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2015.02.016_bb0625","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.biopsych.2012.08.015","article-title":"The effect of CR1 on brain amyloid burden during aging and its modification by APOE genotype","volume":"73","author":"Thambisetty","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mcn.2015.02.016_bb0630","doi-asserted-by":"crossref","first-page":"14673","DOI":"10.1074\/jbc.R113.463281","article-title":"Structural biology of presenilins and signal peptide peptidases","volume":"288","author":"Tomita","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0635","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11763-M","article-title":"ApoE immunoreactivity and microglial cells in Alzheimer's disease brain","volume":"195","author":"Uchihara","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2015.02.016_bb0640","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.neurobiolaging.2012.04.020","article-title":"Identification of Alzheimer disease-associated variants in genes that regulate retromer function","volume":"33","author":"Vardarajan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2015.02.016_bb0645","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.24305","article-title":"Coding mutations in SORL1 and Alzheimer's disease","volume":"77","author":"Vardarajan","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb0650","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","article-title":"Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects","volume":"130","author":"Vassar","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2015.02.016_bb0655","doi-asserted-by":"crossref","first-page":"924-924","DOI":"10.1126\/science.1235505","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models.\u201d","volume":"340","author":"Veeraraghavalu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0660","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0665","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1194653","article-title":"Tau reduction prevents abeta-induced defects in axonal transport","volume":"330","author":"Vossel","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0670","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1021\/bi015794o","article-title":"A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing","volume":"41","author":"Weidemann","year":"2002","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mcn.2015.02.016_bb0675","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cger.2013.07.006","article-title":"Emerging biomarkers in cognition","volume":"29","author":"Wicklund","year":"2013","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.mcn.2015.02.016_bb0680","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","article-title":"Control of peripheral nerve myelination by the \u00df-secretase BACE1","volume":"314","author":"Willem","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mcn.2015.02.016_bb0685","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2015.02.016_bb0690","first-page":"278","article-title":"Alzheimer's disease in Down's syndrome: clinico-pathologic studies","volume":"17","author":"Wisniewski","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.02.016_bb0695","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2015.02.016_bb0700","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the beta secretase BACE1 for Alzheimer's disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcn.2015.02.016_bb9000","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/35024009","article-title":"Nicastrin modulates presenilin-mediated Notch\/Glp1 signal transduction and bAPP processing","volume":"407","author":"Yu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0705","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2015.02.016_bb0710","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2015.02.016_bb0715","doi-asserted-by":"crossref","first-page":"50647","DOI":"10.1074\/jbc.C400473200","article-title":"Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743115000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743115000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T10:35:45Z","timestamp":1651401345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743115000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":142,"alternative-id":["S1044743115000299"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2015.02.016","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future implications of basic and translational research on amyloid-\u03b2 peptide production and removal pathways","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2015.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}